Corrigendum to "Bushen Huoxue Yiqi formula alleviates cardiac fibrosis in ischemic heart failure through SIRT1/Notch1 pathway-mediated EndMT" [Phytomedicine Journal 135 (2024) 156252].

IF 6.7 1区医学 Q1 CHEMISTRY, MEDICINAL

Phytomedicine Pub Date : 2024-12-12 DOI:10.1016/j.phymed.2024.156315

Cong Chen, Jie Wang, Chengzhi Hou, Wenjing Lian, Xueying Zhu, Jun Hu, Chao Liu

引用次数: 0

查看原文本刊更多论文

对《布氏藿香益气方通过SIRT1/Notch1通路介导的EndMT缓解缺血性心力衰竭的心脏纤维化》的更正 [《植物药杂志》135 (2024) 156252]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Phytomedicine 医学-药学

CiteScore

10.30

自引率

5.10%

发文量

670

审稿时长

91 days

期刊介绍： Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.